Abstract 4370773: Predictors of Left Ventricular Function Recovery After Premature Ventricular Complex Ablation: A Retrospective Study

P Pragyat Futela (MetroHealth Medical Center, Cleveland, Ohio, United States) A Aastha Poddar (Mayo Clinic, Rochester, Minnesota, United States) A Arvind Gulati (Mayo Clinic, Rochester, Minnesota, United States) N NIHARIKA PRAVEEN (Mayo Clinic, Rochester, Minnesota, United States) I Iuri Ferreira Felix (Mayo Clinic, Rochester, Minnesota, United States) K Karol Quelal (JOHN H. STROGER JR HOSPITAL OF COOK, Chicago, Illinois, United States) G Gurukripa Kowlgi (Mayo Clinic, Rochester, Minnesota, United States)

Abstract

Background: Catheter ablation of frequent premature ventricular complexes (PVCs) has been demonstrated to improve left ventricular ejection fraction (LVEF) in patients with PVC-induced cardiomyopathy. However, this improvement is not uniformly observed across all patients. Objective: To identify predictors of LVEF improvement following catheter ablation. Methods: This retrospective analysis included adult patients (≥18 years) who underwent PVC catheter ablation at Mayo Clinic, Rochester, between 2021 and 2024. Patients were grouped based on whether they experienced an LVEF improvement of ≥5%. Data on baseline comorbidities,, ECG characteristics, baseline transthoracic echocardiography (TTE), procedural details, and follow-up outcomes at 3-6 months (via Holter monitoring and TTE) were collected. Propensity matching (1:1) was performed using age(caliper=5), sex, and baseline LVEF(caliper=5). Comparative analyses used chi-square and t-tests. Variables with a p-value <0.1 were included in multivariate regression analysis. Results: After propensity matching, 98 patients with LVEF improvement and 98 controls were included. Table 1 summarizes baseline and procedural characteristics, and outcomes. Immediate PVC suppression was more common in the EF improvement group (74.2% vs. 60.4%, p=0.04), and fewer patients in this group were placed on long-term anti-arrhythmic medications (11.2% vs. 27.8%, p<0.01). Multivariate analysis showed that patients without PVC-related symptoms (OR=3.16, p=0.038) had higher odds of LVEF improvement, while those with CKD (OR=0.36, p=0.007) or a coupling interval ≥500 ms (OR=0.38, p=0.002) had lower odds of improvement.

Article Details

Journal Circulation
Volume / Issue Vol. 152, Issue Suppl_3
Published November 04, 2025
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (7)

P

Pragyat Futela

MetroHealth Medical Center, Cleveland, Ohio, United States

A

Aastha Poddar

Mayo Clinic, Rochester, Minnesota, United States

A

Arvind Gulati

Mayo Clinic, Rochester, Minnesota, United States

N

NIHARIKA PRAVEEN

Mayo Clinic, Rochester, Minnesota, United States

I

Iuri Ferreira Felix

Mayo Clinic, Rochester, Minnesota, United States

K

Karol Quelal

JOHN H. STROGER JR HOSPITAL OF COOK, Chicago, Illinois, United States

G

Gurukripa Kowlgi

Mayo Clinic, Rochester, Minnesota, United States